26885-08-5

区域选择: 北京市天津市河北省山西省内蒙古自治区辽宁省吉林省黑龙江省上海市江苏省浙江省安徽省福建省江西省山东省河南省湖北省湖南省广东省广西壮族自治区海南省重庆市四川省贵州省云南省西藏自治区陕西省甘肃省青海省宁夏回族自治区新疆维吾尔自治区台湾省香港特别行政区澳门

英文名称:: Cyclo[glycyl-N5-hydroxy-N5-[(2E)-5-hydroxy-3-methyl-1-oxo-2-penten-1-yl]-L-ornithyl-N5-hydroxy-N5-[(2E)-5-hydroxy-3-methyl-1-oxo-2-penten-1-yl]-L-ornithyl-N5-hydroxy-N5-[(2E)-5-hydroxy-3-methyl-1-oxo-2-penten-1-yl]-L-ornithyl-L-seryl-L-seryl]

英文别名:: Cyclo[glycyl-N5-hydroxy-N5-[(2E)-5-hydroxy-3-methyl-1-oxo-2-penten-1-yl]-L-ornithyl-N5-hydroxy-N5-[(2E)-5-hydroxy-3-methyl-1-oxo-2-penten-1-yl]-L-ornithyl-N5-hydroxy-N5-[(2E)-5-hydroxy-3-methyl-1-oxo-2-penten-1-yl]-L-ornithyl-L-seryl-L-seryl];
2-Pentenohydroxamicacid,N,N',N''-[[11,14-bis(hydroxymethyl)-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexaazacyclooctadecane-2,5,8-triyl]tris(trimethylene)]tris[5-hydroxy-3-methyl-,(E,E,E)- (8CI);
Ferrirubin, deferri- (9CI);
1,4,7,10,13,16-Hexaazacyclooctadecane, cyclic peptide deriv.;
(E,E,E)-Cyclo[glycyl-N5-hydroxy-N5-(5-hydroxy-3-methyl-1-oxo-2-pentenyl)-L-ornithyl-N5-hydroxy-N5-(5-hydroxy-3-methyl-1-oxo-2-pentenyl)-L-ornithyl-N5-hydroxy-N5-(5-hydroxy-3-methyl-1-oxo-2-pentenyl)-L-ornithyl-L-seryl-L-seryl];
Cyclo[glycyl-N5-hydroxy-N5-(5-hydroxy-3-methyl-1-oxo-2-pentenyl)-L-ornithyl-N5-hydroxy-N5-(5-hydroxy-3-methyl-1-oxo-2-pentenyl)-L-ornithyl-N5-hydroxy-N5-(5-hydroxy-3-methyl-1-oxo-2-pentenyl)-L-ornithyl-L-seryl-L-seryl],(E,E,E)-;
Deferrirubin;
Desferrirubin